Optometrists in Diamondhead, MS Accepting Medicare
3 Optometrists found. Showing 1 - 3
 Joseph E Gregory, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 5405 Indian Hill Blvd, Diamondhead, MS 39525 Phone: 228-255-8585 Fax: 228-875-2092 |
 Debra Gregory Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5405 Indian Hill Blvd, Diamondhead, MS 39525 Phone: 228-255-8585 |
 See Side Optical Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5405 Indian Hill Blvd, Diamondhead, MS 39525 Phone: 228-255-8585 |
News Archive
Candidates are betting big on health. Is that what voters really want?
The one thing we know about health care in the 2020 Democratic presidential primary race is that it's a top issue for voters.
Covidien pledges $375,000 to SIRF's discovery campaign
The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Covidien, a manufacturer of medical devices, pharmaceuticals and medical supplies, based in Mansfield, Mass., has pledged $375,000 and is a "Visionary" level supporter.
First patient dosed in NCI-sponsored Phase 1/2 trial of belinostat
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
Translating science into service delivery to achieve Clinton's vision of an AIDS-free generation
In this post in the Huffington Post's "Impact" blog, U.S. Global AIDS Coordinator Ambassador Eric Goosby responds to Secretary of State Hillary Rodham Clinton's speech on HIV/AIDS given at the NIH on Wednesday, in which she called for an "AIDS-free generation," writing that "her vision was an affirmation of the progress made over the past decade, and a mandate to redouble our efforts with global partners to bring the latest scientific advances to bear in order to save lives."
Intezyne announces new patents covering IVECT Method in major pharmaceutical markets
Intezyne today announced the issuance of new patents that cover multiple dimensions of the Company's revolutionary technology platform, the IVECTTM Method, in the major pharmaceutical markets of the United States, Europe, and Japan. All patents are wholly owned by Intezyne.
› Verified 9 days ago
Physical Therapists
Optometrists
Audiologists
Speech-Language Pathologists
Chiropractors
Occupational Therapists